Every year, thousands of Chinese women quietly board planes to Thailand, the United States, and increasingly Europe. Not for vacation, but in pursuit of fertility treatments that are not legally available to them at home.
China’s fertility regulations still bar single women from IVF and egg freezing, and gender selection remains prohibited for everyone. These rules trace back to decades of population control policy. They have created a steady stream of cross-border reproductive care as women look for medical options that mainland clinics cannot legally offer them.
I’m Olivier Verot, founder of Gentlemen Marketing Agency. We’ve spent over a decade helping foreign healthcare providers understand how to reach Chinese patients, and fertility is one of the categories where getting the compliance and the tone right matters more than the ad budget.
In this article, we look at what China’s fertility rules actually say today, what changed in the past two years, and what a foreign clinic or medical tourism agency needs to know before it markets to this audience. We describe the legal framework as it stands. We don’t make medical claims, and we don’t take a position on China’s family policy. That’s not our place, and it’s not what this article is for.
Contents
Fertility Regulations In China
China restricts IVF and egg freezing to married couples. Single women cannot access either procedure legally on the mainland. Gender selection is banned outright, and clinics are required to check proof of marriage before treatment.
Historical Context Of Fertility Regulations (One Child Policy, Two Child Policy)
The One-Child Policy ran from 1979 to 2015 and limited most families to a single child. It prevented an estimated 400 million births and reshaped family structure and expectations for two generations.
To respond to a falling birth rate and an aging population, Beijing introduced the Two-Child Policy in 2015, then moved to a three-child policy in 2021. Neither triggered the rebound officials hoped for. High living costs, housing prices, and career pressure on young women did more to shape family size than the policy ceiling ever did.
That said, national birth numbers ticked up in 2024 for the first time since 2017: 9.54 million births, up 520,000 from 2023, with the total fertility rate rising to 1.14. It’s a small rebound off a low base, not a reversal of the underlying trend, but it matters for how officials talk about family policy going into 2026.
Current Strict Regulations On IVF And Egg Freezing
China’s rules on assisted reproductive technology (ART) still apply almost exclusively to married couples. An unmarried woman cannot get IVF or freeze her eggs at a mainland clinic for non-medical reasons, no matter her age or income.
Unmarried men, by contrast, can freeze sperm without any legal obstacle. That asymmetry is one of the most commonly cited grievances in the domestic debate around these rules. Gender selection stays banned for all patients, married or not.
These restrictions are what send Chinese women looking for treatment overseas. It’s worth separating two things that get conflated: insurance coverage and treatment eligibility. As the next section shows, China has moved fast on the first and has barely moved on the second.
Prohibitions On Gender Selection And Proof Of Marriage
Gender selection is not allowed, and a marriage certificate is mandatory before any fertility treatment starts. Clinics that skip this check risk their license.
This leaves single women and same-sex couples with no legal path to ART in mainland China, regardless of medical need or financial means.
What Changed Since 2023: Insurance Grew, Eligibility Didn’t
This is the part most articles on this topic miss, and it’s the part that matters most if you’re a foreign clinic trying to read the room correctly.
Since 2023, China has expanded medical insurance coverage for assisted reproduction at a pace few expected. Beijing was first: from July 2023, 16 ART procedures, including egg retrieval and embryo transfer, became reimbursable under the city’s basic medical insurance. According to Beijing’s medical insurance bureau, roughly 53,800 insured patients used the benefit in the first stretch, saving an estimated 406 million yuan in out-of-pocket costs, while outpatient volume at Beijing Obstetrics and Gynecology Hospital’s reproductive medicine department rose about 19% with per-cycle costs down close to 70%.
By January 2025, every one of China’s 31 provinces and the Xinjiang Production and Construction Corps had added ART procedures to their basic medical insurance schemes, according to Xinhua’s coverage of the rollout. Heilongjiang was the last to sign on. Reimbursement rates vary by region, from around 60% to 75% of eligible costs in places like Ningxia, and procedure volumes in the first quarter of 2025 were up more than 10% year on year as a result.
What insurance expansion has not touched is who qualifies. The marriage requirement is untouched. Single women still cannot get IVF or freeze eggs for non-medical reasons anywhere on the mainland, insured or not. Two other data points from the past three years show the boundary clearly:
- Sichuan, February 2023: the province decoupled birth registration from marital status, meaning a woman no longer needs a marriage certificate to register a birth locally. Provincial officials were explicit that this is a civil registration change, not a fertility policy change, and it does not extend to ART eligibility.
- Hunan, 2024: the provincial health commission, responding formally to a National People’s Congress deputy’s proposal, acknowledged real demand to conditionally allow egg freezing for single women with documented medical indications, such as before chemotherapy. The commission said it would issue implementing rules once national-level regulation is updated. As of mid-2026, that update has not happened.
So the honest read for 2026 is this: the door hasn’t opened, but the conversation about opening it has moved from provincial silence to provincial health commissions putting it in writing. For a foreign clinic, that’s a market signal worth watching, not a green light to act on yet.
The Social And Cultural Implications Of These Regulations
These rules sit inside a culture that still puts heavy weight on having children for family continuity. Women who don’t, whether by choice or circumstance, often carry a stigma that the men in the same situation rarely face.
The Societal Pressure On Women To Bear Children
Infertility rates in China have climbed over the past two decades, driven by delayed childbirth, lifestyle changes, and environmental factors. At the same time, the social pressure to have a child hasn’t eased even as fewer people can, or want to, meet it on the old timeline.
The Impact Of These Regulations On Single Women And LGBTQ+ Patients
For single women and LGBTQ+ individuals, the marriage requirement removes the legal path to parenthood through ART inside China entirely. That pushes anyone with the means to consider it toward Hong Kong, Southeast Asia, the United States, or Europe, where the same procedures are legal without a marriage certificate.
The financial gap between “insured at home if you qualify” and “self-funded abroad if you don’t” is the whole story of this market. It’s also where the stigma tends to bite hardest: women who travel for treatment often do it quietly, without telling extended family why.
Pushing Chinese Women To Overseas Clinics
The Rising Demand For Egg Freezing And IVF Abroad
China’s domestic ART market was valued at over USD 2.3 billion in 2023 and is forecast to approach USD 3.9 billion by 2030, a roughly 7.8% annual growth rate, per China Briefing’s market analysis. That’s the domestic number. The overseas segment, the women who can’t or won’t wait for eligibility to change, sits on top of it and is much harder to size precisely because so much of it moves through private referrals rather than public statistics.
What we can say from working with clinics in this space: demand hasn’t slowed as insurance coverage expanded. If anything, wider awareness of ART as a medical category, driven partly by the insurance news itself, has brought more women into the conversation, including some who then discover they don’t qualify at home and start looking abroad.
The Role Of Medical Tourism Agencies
Medical tourism agencies connect Chinese patients with overseas clinics, handling travel, appointment scheduling, translation, and often a first round of vetting on the clinic’s licensing and track record. As the pool of informed patients grows, so does scrutiny of the agencies themselves. Patients increasingly ask for verifiable success-rate data and clinic credentials before booking, not just a glossy brochure.
A Foreign Clinic’s Story: What Worked And What Didn’t
Fredrik runs a fertility clinic in Sweden that had treated a handful of Chinese patients over the years, mostly word of mouth through existing European clients. He wanted to grow that number deliberately and came to us after a first attempt fell flat.
His team had run paid search ads in English targeting “IVF Sweden” and boosted a few WeChat posts written by a European copywriter, translated afterward into Mandarin. Over four months, it generated 340,000 yuan in ad spend and exactly six inquiries, none of which converted into a booked consultation. The messaging led with success rates and clinical technology, the same pitch that works with Swedish and German patients.
The problem wasn’t the clinic. It was that the content answered questions Chinese patients weren’t asking yet. Before a Chinese woman considering fertility treatment abroad cares about your lab equipment, she wants to know: is this legal for me to do, what does the whole trip cost including things a brochure doesn’t mention, and can I trust an agency that isn’t hiding fees or overselling outcomes.
We rebuilt the approach around that order of questions. A Xiaohongshu content series, written natively in Chinese by someone who understood the regulatory context, walked through the legal picture in China, what the Sweden process actually involves step by step, and a transparent, itemized cost breakdown with no hidden add-ons. No success-rate claims, no urgency language, no “book now” pressure. A private WeChat group let existing patients answer questions from prospective ones directly, which did more for trust than anything the clinic could publish itself.
Over the following eight months, the clinic booked 14 consultations from Chinese patients and completed 9 treatment cycles, at a lower total marketing cost than the failed campaign. The shift wasn’t a bigger budget. It was answering the trust question before the medical one, and being upfront enough about the legal framework that patients didn’t have to wonder what the clinic was avoiding saying.
The Business Perspective
Foreign fertility clinics and medical tourism agencies have a real opportunity here, but it comes with more regulatory and ethical weight than most categories we work in.
